Möbus, V., Jackisch, C., Lück, H. J., du Bois, A., Thomssen, C., Kuhn, W., Nitz, U., Schneeweiss, A., Huober, J., Harbeck, N., von Minckwitz, G., Runnebaum, I. B., Hinke, A., Konecny, G. E., Untch, M., Kurbacher, C., & , (2018). ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial. Annals of oncology, 29, 178–185. http://access.bl.uk/ark:/81055/vdc_100095500500.0x00002b